BR112018074820A2 - surfactantes não iónicos para a redução de tecido adiposo - Google Patents

surfactantes não iónicos para a redução de tecido adiposo

Info

Publication number
BR112018074820A2
BR112018074820A2 BR112018074820-0A BR112018074820A BR112018074820A2 BR 112018074820 A2 BR112018074820 A2 BR 112018074820A2 BR 112018074820 A BR112018074820 A BR 112018074820A BR 112018074820 A2 BR112018074820 A2 BR 112018074820A2
Authority
BR
Brazil
Prior art keywords
adipose tissue
reduction
nonionic surfactants
composition
reducing
Prior art date
Application number
BR112018074820-0A
Other languages
English (en)
Other versions
BR112018074820B1 (pt
Inventor
Travers Stephan
Gliem Petra
Lotter Matthias
Otto Joachim
Original Assignee
Chemische Fabrik Kreussler & Co. Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemische Fabrik Kreussler & Co. Gmbh. filed Critical Chemische Fabrik Kreussler & Co. Gmbh.
Publication of BR112018074820A2 publication Critical patent/BR112018074820A2/pt
Publication of BR112018074820B1 publication Critical patent/BR112018074820B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q90/00—Cosmetics or similar toiletry preparations for specific uses not provided for in other groups of this subclass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Abstract

a invenção diz respeito a uma composição para reduzir tecido adiposo, à utilização da referida composição e a um método para reduzir tecido adiposo indesejado.
BR112018074820-0A 2016-05-30 2017-05-30 Surfactantes não iónicos para a redução de tecido adiposo BR112018074820B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16171904.2 2016-05-30
EP16171904.2A EP3251654A1 (de) 2016-05-30 2016-05-30 Nichtionische tenside zur reduktion von fettgewebe
PCT/EP2017/062956 WO2017207520A1 (de) 2016-05-30 2017-05-30 Nichtionische tenside zur reduktion von fettgewebe

Publications (2)

Publication Number Publication Date
BR112018074820A2 true BR112018074820A2 (pt) 2019-03-06
BR112018074820B1 BR112018074820B1 (pt) 2022-08-23

Family

ID=56096964

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018074820-0A BR112018074820B1 (pt) 2016-05-30 2017-05-30 Surfactantes não iónicos para a redução de tecido adiposo

Country Status (7)

Country Link
US (1) US11166892B2 (pt)
EP (2) EP3251654A1 (pt)
JP (2) JP2019517489A (pt)
CN (1) CN109414385A (pt)
BR (1) BR112018074820B1 (pt)
ES (1) ES2852225T3 (pt)
WO (1) WO2017207520A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
KR20190121699A (ko) * 2018-04-18 2019-10-28 (주)인벤티지랩 데옥시콜린산을 포함하는 피하 주사용 조성물 및 이의 제조 방법
IT201800006109A1 (it) 2018-06-07 2019-12-07 Polidocanolo per uso come immunomodulatore
WO2020081590A1 (en) 2018-10-16 2020-04-23 Rotunda Adam M Alcohol-based compositions and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164320A (en) * 1990-03-05 1992-11-17 Becton, Dickinson And Company Method for lysing hard liposomes using polyethyleneglycol mono-n-alkyl ethers
AU2002251831A1 (en) 2001-01-30 2002-08-12 The Regents Of The University Of Michigan Methods for sustained release local delivery of drugs for ablation of unwanted tissue
US20060062736A1 (en) * 2003-11-17 2006-03-23 Wright David D I Therapeutic foam
US9861836B2 (en) 2005-06-16 2018-01-09 Biosense Webster, Inc. Less invasive methods for ablation of fat pads
CN100364546C (zh) * 2005-09-16 2008-01-30 陕西天宇制药有限公司 聚桂醇注射液及其制备方法
CN107334661A (zh) * 2007-10-02 2017-11-10 库斯有限公司 局部施用性化妆品或药物组合物
WO2010132562A2 (en) * 2009-05-12 2010-11-18 Ohio University Transdermal delivery of metformin
EP2793813A1 (en) 2011-12-21 2014-10-29 Motolese, Pasquale Cosmetic composition and uses thereof in the treatment of lipodystrophies
EP2961858B1 (en) * 2013-03-01 2022-09-07 Si02 Medical Products, Inc. Coated syringe.
US9687455B2 (en) * 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
CA2872279C (en) * 2014-11-21 2018-06-12 Pankaj Modi Topical lipolysis compositions and methods
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue

Also Published As

Publication number Publication date
JP2022003077A (ja) 2022-01-11
CN109414385A (zh) 2019-03-01
WO2017207520A1 (de) 2017-12-07
BR112018074820B1 (pt) 2022-08-23
US11166892B2 (en) 2021-11-09
EP3463273B1 (de) 2020-11-11
ES2852225T3 (es) 2021-09-13
EP3251654A1 (de) 2017-12-06
JP2019517489A (ja) 2019-06-24
US20200323756A1 (en) 2020-10-15
EP3463273A1 (de) 2019-04-10

Similar Documents

Publication Publication Date Title
CL2018002359A1 (es) Métodos para usar agonistas de fxr
BR112019006160A2 (pt) composições e métodos para o tratamento das condições oftálmicas
CL2017003142A1 (es) Composiciones que comprenden cepas bacterianas
UY36357A (es) Composiciones y métodos para la inhibición de la expresión génica de hao1 (hidroxiácido oxidasa 1 (glicolato oxidasa))
CL2018000198A1 (es) Composiciones de arni de transtiretina (ttr) y métodos para su uso para el tratamiento o prevencion de enfermedades asociadas con ttr
CO2017005034A2 (es) Tratamiento de convulsiones con fosfatasa alcalina recombinante
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
CR20190271A (es) Anticuerpos antitau y métodos de uso
BR112016026950A2 (pt) composições de rnai para angiotensinogênio (agt) e métodos de uso das mesmas
BR112017009374A2 (pt) ?composições de ramnolipídeo de baixa viscosidade concentradas?
BR112018006696A2 (pt) métodos e sistemas para obter óleo a partir de uma composição de vinhoto
BR112017015580A2 (pt) composição de limpeza para lavagem de louça, e, método para formar uma composição de limpeza para lavagem de louça
CL2019002251A1 (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos.
BR112017002060A2 (pt) novo uso
CL2018000597A1 (es) Métodos para tratar enfermedades inflamatorias
BR112018074820A2 (pt) surfactantes não iónicos para a redução de tecido adiposo
CY1124338T1 (el) Αναστολεις 3-φωσφογλυκερικης αφυδρογονασης και χρησεις αυτων
CY1123267T1 (el) Κρυσταλλικες μορφες 2-(tpit-boytyλamino)-4-((1r,3r,4r)-3-yδpoξy-4-μεθυλοκυκλοεξυλαμινο)-πυριμιδινο-5-καρβοξαμιδιου
CL2019000049A1 (es) Procesos para la preparación de oxipicolinamidas 4 - alkoxi - (acil o aquil).
BR112018070497A2 (pt) métodos e formulações farmacêuticas para tratamento de condições oculares
BR112018069303A2 (pt) método para tratamento de uma infecção
DK3497085T3 (da) Sulfonamider som gpr40- og gpr120-agonister
CO2017001389A2 (es) Compuestos de azetidiniloxifenilpirrolidina
BR112019020338A8 (pt) Composição para produção de tagatose, e, método de produção de tagatose
BR112018010692A8 (pt) composições imunoestimuladoras, usos de melanina ou de um precursor da melanina e método para obter uma composição imunoestimuladora

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/05/2017, OBSERVADAS AS CONDICOES LEGAIS